Drug Analysis Service and Cannabis Laboratories

Health Canada’s Drug Analysis Service (DAS) and Cannabis Laboratory (CL) operates laboratories across Canada that analyze suspected illegal substances seized by Canadian law enforcement agencies.

  • Last updated: 2023-06-23

At-a-glance reports

At-a-glance: New psychoactive substances in Canada – 2022 New

The aim of this report is to describe new psychoactive substances that emerged in Canada in 2022 based on samples submitted to the Drug Analysis Service by law enforcement agencies and public health partners.

At-a-glance: The emergence of Nitazenes and Brorphine in Canada since 2019

This report aims at presenting the result of a pilot project based on a collaborative work between the Drug Analysis Service, the Canada Border Services Agency (CBSA) and the Royal Canadian Mounted Police (RCMP) related to Nitazenes and Brorphine in order to draw a more complete picture of the situation in Canada.

At-a-glance: Newly reported psychoactive substances in Canada 2020-2021

At-a-glance: Newly reported psychoactive substances in Canada 2020-2021

The aim of this report is to describe new psychoactive substances which emerged in Canada since 2020.

Infosheet

Emergence of Desalkylgidazepam, a novel benzodiazepine in Canada

Emergence of Desalkylgidazepam, a novel benzodiazepine in Canada New

This short report provides quick statistics on Desalkylgidazepam, the most identified new psychoactive substance in Canada in 2022 based on samples submitted to the Drug Analysis Service by law enforcement agencies and public health partners.

Spotlight reports

Spotlight : The evolution of Fentanyl in Canada over the past 11 years

Spotlight: The evolution of Fentanyl in Canada over the past 11 years

The aim of this spotlight report is to characterize trends in Fentanyl identifications across Canada since 2012 and draw a more comprehensive picture of Fentanyl in Canada based on exhibits seized and submitted to the Drug Analysis Service for analysis by law enforcement agencies.

Spotlight : The emergence of Xylazine in Canada

Spotlight: The emergence of Xylazine in Canada

The aim of this spotlight report is to characterize trends in Xylazine identifications across Canada since 2012 and draw a more comprehensive picture of Xylazine in Canada based on exhibits seized and submitted to the Drug Analysis Service for analysis by law enforcement agencies.

Did you find what you were looking for?

What was wrong?

Answers to frequently asked questions can be found in the Understanding the data section!

(Don’t include any personal information. Note that you will not receive a reply.)
Maximum 300 characters

Thank you for your feedback

Date modified: